跳至主要内容
临床试验/ISRCTN18100253
ISRCTN18100253进行中(未招募)未知

Effect of maritime pine bark extract (Pycnogenol®) on CoQ10 levels and wellbeing in patients treated with statins

Horphag Research (Switzerland)0 个研究点目标入组 60 人开始时间: 2023年3月10日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients with different diagnoses (e.g. CVD, hypertension) who will be treated with any type of statin for the first time and in a dose that will be determined individually based on the established overall CV risk with the aim of achieving target lipid values

排除标准

  • 1. Aged < 19 and > 60 years old
  • 2. Acute myocardial infarction (IM) or less than 3 months after IM
  • 3. Active oncological disease
  • 4. Hypothyroidism
  • 5. Diabetes Mellitus
  • 6. Chronic inflammatory disease (e.g. rheumatoid arthritis)
  • 7. Unable/unwilling to sign an informed consent
  • 8. Unable/unwilling to provide samples of biological material as needed

研究者

发起方
Horphag Research (Switzerland)

相似试验